Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 3Rhabdoid Tumor 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Ganglioneuroblastoma 2Central Nervous System Neoplasms 2Astrocytoma 2Oligodendroglioma 1Myelodysplastic Syndromes 1Medulloblastoma 1Leukemia 1Inflammatory Breast Neoplasms 1Graft vs Host Disease 1Choroid Plexus Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 12Temozolomide 8Vincristine 6Procarbazine 5Lomustine 4Carboplatin 2Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Methylphenidate 1Methotrexate 1Isotretinoin 1Fentanyl 1Etoposide 1Donepezil 1DNA Methylation 1Cyproheptadine 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Oligodendroglioma × Thiotepa × Clear all
NCT00392886 2013-12-18

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
120 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡